Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Venetoclax in Chronic Lymphocytic Leukemia Effectiveness and Real-life Treatment Management

NCT03415035 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03415035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03415035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Venetoclax in Chronic Lymphocytic Leukemia Effectiveness and Real-life Treatment Management
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
March 9, 2018
Completion date
June 17, 2026
Enrollment
269 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

cancer - chronic lymphocytic leukemia